Webster

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Psoriasis3 trials

Phase

• Phase 23 trials

Status

• Active, not recruiting2 trials
• Recruiting1 trial

Lead sponsor

• Oruka Therapeutics, Inc.3 trials

Running trials

• Active, not recruiting

  Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis

  NCT07474792· Phase 2· Oruka Therapeutics, Inc.· Source

• Recruiting

  An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis

  NCT07449702· Phase 2· Oruka Therapeutics, Inc.· Source

  Contact: Oruka Therapeutics Investigative Site

• Active, not recruiting

  Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis

  NCT07290569· Phase 2· Oruka Therapeutics, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Psoriasis1 recruiting